A Prospective, Multicenter, Open Label Extension Study to Evaluate the Long Term Safety of OTX-TP
Latest Information Update: 01 Mar 2023
At a glance
- Drugs Travoprost (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Ocular Therapeutix
- 10 Aug 2021 Status changed from active, no longer recruiting to completed.
- 05 Aug 2021 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Aug 2019).
- 15 Aug 2019 Status changed from planning to active, no longer recruiting.